SHEL
Dead / Abandoned — Abandoned — after publication (as of 30 Nov 2018)
What this means for you
This application is over — abandoned 30 Nov 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87548951
- Mark type
- Stylized text
- Filed
- 31 Jul 2017
- Published for opposition
- 05 Jun 2018
- Abandoned
- 30 Nov 2018
- Attorney of record
- Gregory S. Bernabeo
Goods and services
- Class 001 — Chemicals: antibodies for purification purposes, for laboratory or scientific research use; antibodies for commercial use, namely, for industrial, scientific or research use; antibodies for commercial use, namely, for medical laboratory use; enzymes for scientific and research purposes; monoclonal antibodies for in vitro scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; cell cultures for laboratory and scientific research use; nucleic acid sequences for laboratory and scientific research use; cloning vehicles in the nature of plasmids and recombinant nucleic acid variations thereof for in vitro and in vivo laboratory and scientific research use
- Class 042 — Scientific and technological services: genetic engineering services, namely, scientific and medical research in the field of genetic engineering; biotechnology services, namely, research and development for new products in the field of biotechnology; scientific and technological services, namely, research and development in the field of design and development of biologic molecules, recombinant expression products, and drug products with a particular emphasis on proteins that are secreted by cells; scientific development services in the field of antibodies, namely, custom antibody production, development and generation for others; scientific laboratory services, namely, performing hybridoma cell line development; scientific research and development, namely, development of antibodies for others; scientific, technological and medical research services, namely, providing protein expression, antibody production, cell line establishment, cell culture production of proteins, and hybridoma development for scientific and medical research use
Owner
- OCMS BIO, LLC, WYNNEWOOD, PA, US
- Framework Bio, LLC, Wynnewood, PA, US
- Framework Bio, LLC, Wynnewood, PA, US
Prosecution history
- 30 Nov 2018 — ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
- 30 Nov 2018 — ABANDONMENT - AFTER PUBLICATION
- 28 Nov 2018 — TEAS EXPRESS ABANDONMENT RECEIVED
- 26 Jun 2018 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 13 Jun 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Jun 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Jun 2018 — PUBLISHED FOR OPPOSITION
- 16 May 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Apr 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Apr 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Apr 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Apr 2018 — ASSIGNED TO LIE
- 10 Apr 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Apr 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Apr 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED